Sodipo v. United States, Crim. No. ELH-06-0444

CourtUnited States District Courts. 4th Circuit. United States District Court (Maryland)
Writing for the CourtEllen Lipton Hollander United States District Judge
Docket NumberCrim. No. ELH-06-0444
Decision Date17 November 2016


Crim. No. ELH-06-0444


November 17, 2016

(Related Civil No. ELH-13-2871)


Following a lengthy trial by jury, Steven Abiodun Sodipo and his codefendant, Callixtus Nwaehiri, were convicted on July 31, 2008, of various offenses, including conspiracy to distribute and possess with intent to distribute hydrocodone, under 21 U.S.C. § 846.1 ECF 480; ECF 498. On December 12, 2008, Chief Judge Benson E. Legg sentenced Sodipo to 60 months' imprisonment, followed by two years of supervised release. ECF 488; ECF 498.2

On September 30, 2013, Sodipo, who is now self-represented, filed a petition to vacate, set aside, or correct his sentence, pursuant to 28 U.S.C. § 2255 (ECF 672), along with a supporting memorandum and exhibits. See ECF 672-1 to ECF 627-9. A redacted petition (ECF 673) was also submitted, along with a supporting memorandum (ECF 673-1) and several exhibits (ECF 673-2 to ECF 673-9) (collectively, "Petition").3 The government opposes the Petition.

Page 2

ECF 675 ("Opposition"). Sodipo has replied (ECF 679, "Reply"), and has included an Affidavit. Id. at 12-14.4

Under 28 U.S.C. § 2255(b), a hearing is required "[u]nless the motion and the files and the records of the case conclusively show that the prisoner is entitled to no relief...." This is such a case; no hearing is necessary. For the reasons that follow, I shall deny the Petition.

I. Factual and Procedural Background

Sodipo was a licensed pharmacist in Maryland and, along with Nwaehiri, he was a part owner and operator of NewCare Home Health Services, Inc., also known as NewCare Pharmacy ("NewCare"). See Joint Appendix ("JA") at 976-78;5 ECF 682 at 1. In 2005, NewCare contracted with a Florida-based distribution business (the "Florida Headquarters"), which consisted of several corporations, to fill prescriptions over the Internet. See ECF 673-1 at 3; ECF 675 at 4-5. Patients from all 50 states contacted the Florida Headquarters; Florida-based doctors employed by the Florida Headquarters issued prescriptions to those patients without a face-to-face meeting; and NewCare filled the prescriptions. See ECF 675 at 3, 5. The vast majority of the thousands of prescriptions filled by NewCare were for hydrocodone, a highly addictive prescription painkiller, which is classified as a Schedule III controlled substance under the

Page 3

Controlled Substances Act ("CSA"), 21 U.S.C. § 801 et seq. See ECF 675 at 3, 8-9; see, e.g., JA at 1460; JA at 1489.

On October 4, 2006, Sodipo and several others were indicted on one count of conspiracy to distribute and possess with intent to distribute a controlled substance, "outside the scope of professional practice and not for a legitimate medical purpose," i.e., "at least eight (8) million dosage units of hydrocodone. . . ." ECF 1 at 1 (Indictment); see also ECF 675 at 1. On September 19, 2007, a Superseding Indictment was filed as to multiple defendants, charging additional crimes. ECF 177 (Superseding Indictment); see also ECF 675 at 1-2.

At trial, the government produced evidence that various warning signs alerted, or should have alerted, Sodipo and his coconspirators to the fact that many of NewCare's customers were abusing hydrocodone, and that the prescriptions completed by the Florida Headquarters were not for legitimate medical needs. For example, staff members testified that they received calls from angry and agitated customers complaining about slightly incorrect pill counts and from others complaining that their relatives, who were NewCare customers, were addicted to hydrocodone. JA at 883-84; JA at 1080-81; JA at 1085. Fed-Ex called to complain about deliveries in neighborhoods with heavy drug use. JA at 889.

Notably, NewCare received "two to ten" after-hours calls a night from hysterical customers who had not received their drugs or had received incorrect pill counts. Supp. Joint App'x ("SJA") at 101-102. Sodipo was aware of these calls. JA at 884-90. In addition, staff members expressed concern to Sodipo and Nwaehiri about the validity of the prescriptions they were filling, because the majority of the prescriptions were for hydrocodone and most of the patients did not live near the Florida-based medical providers who prescribed the hydrocodone. JA at 1381-86; SJA at 83; JA at 879-890; JA at 973. Sodipo also made misrepresentations about

Page 4

the nature of NewCare's business to state regulators, NewCare's suppliers, and NewCare's staff. See, e.g., JA at 990-91; JA at 1385-86; SJA at 85; JA at 853-57; SJA at 164-65; SJA at 136-37; JA at 1210-11.

On July 31, 2008, after an eight-week trial before then Chief Judge Benson E. Legg, a jury convicted Sodipo of conspiracy to distribute and possess with intent to distribute hydrocodone, in violation of 21 U.S.C. § 846; six counts of distribution of hydrocodone and aiding and abetting, in violation of 21 U.S.C. § 841(a) and 18 U.S.C. § 2; conspiracy to launder monetary instruments and two counts of money laundering, in violation, respectively, of 18 U.S.C. §§ 1956(h) and 1957(a); and filing a false tax return, in violation of 26 U.S.C. § 7206(1). See ECF 480, ECF 498; see also ECF 177.

Judge Legg held a sentencing hearing on December 2, 2008. ECF 45. It resumed on December 12, 2008. ECF 488. See also ECF 498 (Judgment). As noted, Sodipo received a sentence of five years' imprisonment. ECF 488; ECF 498.

On December 17, 2008, Sodipo appealed his conviction and sentence to the Fourth Circuit. ECF 489. Nwaehiri also appealed. Both argued that the trial court erred in denying the defendants' motion for a mistrial on grounds that a government witness testified about evidence the Court had ruled inadmissible, and that the prosecutor had made improper statements during closing arguments. United States v. Sodipo, 467 F. App'x 161, 162-63 (4th Cir. 2012) (per curiam), cert. denied, ___U.S.___, 133 S. Ct. 281 (2012), and cert. denied, ___U.S.___, 133 S. Ct. 457 (2012). The defendants also argued that the District Court erred in denying their motion for new trial, "because the court failed to ensure that the jury began deliberations anew when the court replaced a juror with an alternate after deliberations were in progress." Sodipo, 467 F. App'x at 163. Sodipo's appellate counsel was also his trial counsel.

Page 5

The Fourth Circuit affirmed the defendants' convictions. Id. Sodipo's petition for writ of certiorari was denied by the Supreme Court on October 1, 2012. Sodipo v. United States, ___U.S.___, 133 S. Ct 281 (2012). On September 30, 2013, Sodipo timely filed his Petition. ECF 672; ECF 673. See 28 U.S.C. 2255(f) (providing a one-year limitations period for the filing of a petition, dating from the date of finality of the judgment).

As noted, this case was reassigned to me on January 28, 2016. See Docket. By that point, Sodipo's two-year period of supervised release had expired. Therefore, by Order of March 18, 2016 (ECF 691), I asked Sodipo to advise the Court whether he wished to pursue his Petition. Id. The Clerk docketed correspondence from Sodipo on April 4, 2016, advising the Court of his desire to pursue his Petition. ECF 693.

Additional facts are included in the Discussion.

II. Standard of Review

Pursuant to 28 U.S.C. § 2255(a), a prisoner in federal custody may "move the court which imposed the sentence to vacate, set aside or correct the sentence," but only on certain grounds: "that the sentence was imposed in violation of the Constitution or laws of the United States, or that the court was without jurisdiction to impose such sentence, or that the sentence was in excess of the maximum authorized by law, or is otherwise subject to collateral attack. . . ." See also United States v. Newbold, 791 F.3d 455, 459 (4th Cir. 2015).

Collateral attack is not a substitute for direct appeal; failure to raise certain issues on direct appeal may render them procedurally defaulted on post-conviction review. United States v. Frady, 456 U.S. 152, 165 (1982); accord Bousely v. United States, 523 U.S. 614, 630 (1998). As a general rule, a petitioner who fails to raise a claim on direct appeal is barred from raising the claim on collateral review. Sanchez-Llamas v. Oregon, 548 U.S. 331, 350-51 (2006).

Page 6

However, this bar generally does not apply to claims pertaining to ineffective assistance of counsel. See, e.g., Massaro v. United States, 538 U.S. 500, 503-04 (2003).

Under 28 U.S.C. § 2255(b), the post-conviction court must hold a hearing "[u]nless the motion and the files and records conclusively show that the prisoner is entitled to no relief. . . ." See, e.g., United States v. White, 366 F.3d 291, 302 (4th Cir. 2004). Courts have determined that a hearing is not necessary where "the motion . . . fail[s] to allege sufficient facts or circumstances upon which the elements of constitutionally deficient performance might properly be found [or] where the defendant has failed to present any affidavits or other evidentiary support for the naked assertions contained in his motion." United States v. Taylor, 139 F.3d 924, 933 (D.C. Cir. 1998) (internal quotation marks and citation omitted); accord United States v. McGill, 11 F.3d 223, 225-26 (1st Cir. 1993). On the other hand, a hearing is generally "required when a movant presents a colorable Sixth Amendment claim showing disputed material facts and a credibility determination is necessary to resolve this issue." United States v. Robertson, 219 Fed. App'x 286, 286 (4th Cir. 2007); see also United States v. Ray, 547 Fed. App'x 343, 345 (4th Cir. 2013).

Of course, a self-represented litigant is generally "held to a 'less stringent standard[ ]' than is a lawyer, and the Court must liberally construe his claims, no matter how 'inartfully' pled." Morrison v. United States, RDB-12-3607, 2014 WL 979201, at *2 (D. Md. Mar. 12, 2014) (internal citations omitted); see Erickson v. Pardus, 551 U.S....

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT